Nutanix IncNTNX
Price$71.52

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.7B+28.0% YoYTTM through 30 Apr 2026
Net Income $275.9MTTM through 30 Apr 2026
Free Cash Flow $770.9MTTM through 30 Apr 2026

Margins

Current
Gross Margin86.9%
EBITDA Margin11.2%
Operating Margin10.0%
Net Margin10.0%

Returns

-38.0%ROE
8.1%ROA
-284.6%ROIC

Balance Sheet Health

Debt / Equity-1.86x
Current Ratio1.89x
Net Debt-$591.3Mnet cash position
Cash & Equivalents$718.8M

Quality Metrics

Altman Z-Score2.12
Piotroski F-Score7 / 9
FCF Margin28.0%
Rule of 4031.1
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.5B
Diluted EPS$0.95TTM
'20'21'22'23'24'25
FY2025: $640.52

Dividend

No dividend

Capital Allocation

R&D Spend$779.5M
Capex Intensity1.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.